Evidence for D2 receptor mediation of amphetamine-induced normalization of locomotion and dopamine transporter function in hypoinsulinemic rats

Journal of Neurochemistry

Volumn 101, Issue 1, 2007, Pages 151-159

  Sevak, Rajkumar J ^a   Owens, W Anthony ^b   Koek, Wouter ^a   Galli, Aurelio ^c   Daws, Lynette C ^a,b   France, Charles P ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; D2 receptor; Dopamine clearance; Insulin; Locomotion; Raclopride

Indexed keywords

AMPHETAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR; GLUCOSE; RACLOPRIDE; SODIUM CHLORIDE; STREPTOZOCIN;

AMPEROMETRY; ANIMAL EXPERIMENT; ARTICLE; CHRONOBIOLOGY; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; GLUCOSE BLOOD LEVEL; HYPOINSULINEMIA; INSTRUMENTAL CONDITIONING; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY; STREPTOZOCIN DIABETES;

AMPHETAMINE; ANIMALS; BLOOD GLUCOSE; BRAIN; BRAIN CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DOPAMINE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG RESISTANCE; HYPERKINESIS; INSULIN; MALE; RACLOPRIDE; RATS; RECEPTORS, DOPAMINE D2;

RATTUS;

EID: 33947227831     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04358.x     Document Type: Article

References (46)

1. Abbracchio M., Di Luca M., Di Giulio A., Cattabeni F., Tenconi B. and Gorio A. (1989) Denervation and hyperinnervation in the nervous system of diabetic animals: III. Functional alterations of G proteins in diabetic encephalopathy. J. Neurosci. Res. 24, 517-523.
2. Amano T., Matsubayashi H., Seki T., Sasa M. and Sakai N. (2003) Repeated administration of methamphetamine causes hypersensitivity of D2 receptor in rat ventral tegmental area. Neurosci. Lett. 347, 89-92.
3. Amit Z. and Smith B. (1992) Remoxipride, a specific D2 dopamine antagonist: an examination of its self-administration liability and its effects on d-amphetamine self-administration. Pharmacol. Biochem. Behav. 41, 259-261.
4. Bardo M. T., Valone J. M. and Bevins R. A. (1999) Locomotion and conditioned place preference produced by acute intravenous amphetamine: role of dopamine receptors and individual differences in amphetamine self-administration. Psychopharmacology (Berl) 143, 39-46.
5. Bormann N. and Cunningham C. (1998) Ethanol-induced conditioned place aversion in rats: effect of interstimulus interval. Pharmacol. Biochem. Behav. 59, 427-432.
6. Cai G., Zhen X., Uryu K. and Friedman E. (2000) Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D (2) dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats. J. Neurosci. 20, 1849-1857.
7. Carvelli L., Moron J. A., Kahlig K. M. et al. (2002) PI 3-kinase regulation of dopamine uptake. J. Neurochem. 81, 859-869.
8. Cass W. A. and Gerhardt G. A. (1994) Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci. Lett. 176, 259-263.
9. Chester J. A. and Cunningham C. L. (1998) Modulation of corticosterone does not affect the acquisition or expression of ethanol-induced conditioned place preference in DBA/2J mice. Pharmacol. Biochem. Behav. 59, 67-75.
10. Collins R. J., Weeks J. R., Cooper M. M., Good P. I. and Russell R. R. (1984) Prediction of abuse liability of drugs using IV self-administration in rats. Psychopharmacology (Berl) 82, 6-13.
11. Daws L. C., Irvine R. J., Callaghan P. D., Toop N. P., White J. M. and Bochner F. (2000) Differential behavioral and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in rat. Prog. Neuropsychopharmacol. Biol. Psychiat. 24, 955-977.
12. Dickinson S. D., Sabeti J., Larson G. A. et al. (1999) Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J. Neurochem. 72, 148-156.
13. Ericson H., Radesater A. C., Servin E., Magnusson O. and Mohringe B. (1996) Effects of intermittent and continuous subchronic administration of raclopride on motor activity, dopamine turnover and receptor occupancy in the rat. Pharmacol. Toxicol. 79, 277-286.
14. Figlewicz D. P., Szot P., Chavez M., Woods S. C. and Veith R. C. (1994) Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain. Res. 644, 331-334.
15. Galici R., Galli A., Jones D. J., Sanchez T. A., Saunders C., Frazer A., Gould G. G., Lin R. Z. and France C. P. (2003) Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats. Neuroendocrinology 77, 132-140.
16. Garcia B. G., Wei Y., Moron J. A., Lin R. Z., Javitch J. A. and Galli A. (2005) Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol. Pharmacol. 68, 102-109.
17. Hiroi N. and White N. M. (1991) The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas. Brain. Res. 552, 141-152.
18. Kamei J. and Ohsawa M. (1996) Effects of diabetes on methamphetamine- induced place preference in mice. Eur. J. Pharmacol. 318, 251-256.
19. Kebabian J. W., Tarazi F. I., Kula N. S. and Baldessarini R. J. (1997) Compounds selective for dopamine receptor subtypes. Drugs Discov. Today 2, 333-340.
20. Kihara T., Shimohama S., Sawada H., Honda K., Nakamizo T., Kanki R., Yamashita H. and Akaike A. (2002) Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade. J. Neurosci. Res. 70, 274-282.
21. Kuhn C. M. and Schanberg S. M. (1978) Metabolism of amphetamine after acute and chronic administration to the rat. J. Pharmacol. Exp. Ther. 207, 544-554.
22. Lozovsky D., Saller C. F. and Kopin I. J. (1981) Dopamine receptor binding is increased in diabetic rats. Science 214, 1031-1033.
23. Marquis K. L., Webb M. G. and Moreton J. E. (1989) Effects of fixed ratio size and dose on phencyclidine self-administration by rats. Psychopharmacology (Berl) 97, 179-182.
24. Mayfield R. D. and Zahniser N. R. (2001) Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Mol. Pharmacol. 59, 113-121.
25. Meehan S. M. and Schechter M. D. (1998) LSD produces conditioned place preference in male but not female fawn hooded rats. Pharmacol. Biochem. Behav. 59, 105-108.
26. Meiergerd S. M., Patterson T. A. and Schenk J. O. (1993) D2 receptors may modulate the function of the striatal transporter for DA: Kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61, 764-767.
27. Melikian H. E. and Buckley K. M. (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19, 7699-7710.
28. Moron J. A., Zakharova I., Ferrer J. V. et al. (2003) Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J. Neurosci. 23, 8480-8488.
29. Nair V. D. and Sealfon S. C. (2003) Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor. J. Biol. Chem. 278, 47 053-47 061.
30. Neisewander J. L., McDougall S. A., Bowling S. L. and Bardo M. T. (1990) Conditioned taste aversion and place preference with buspirone and gepirone. Psychopharmacology (Berl) 100, 485-490.
31. Owens W. A., Sevak R. J., Galici R., Galli A., France C. P. and Daws L. C. (2005) Deficits in dopamine clearance and locomotion in hypoinsulinemic rats are restored by repeated administration of amphetamine. J. Neurochem. 94, 1402-1410.
32. Patterson T. A., Brot M. D., Zavosh A., Schenk J. O., Szot P. and Figlewicz D. P. (1998) Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology 68, 11-20.
33. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
34. Ralph R. J., Varty G. B., Kelly M. A., Wang Y. M., Caron M. G., Rubinstein M., Grandy D. K., Low M. J. and Geyer M. A. (1999) The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J. Neurosci. 19, 4627-4633.
35. 3H] spiroperidol. Behav. Neurosci. 99, 831-841.
36. Seeman P., Tallerico T., Ko F., Tenn C. and Kapur S. (2002) Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenge. Synapse 46, 235-239.
37. Serri O., Renier G. and Somma M. (1985) Effects of alloxan-induced diabetes on dopaminergic receptors in rat striatum and anterior pituitary. Horm. Res. 21, 95-101.
38. Sevak R. J. and France C. P. (2005) Some Behavioral Effects of Dopamine Receptor Agonists and Antagonists Are Decreased in Diabetic Rats. Program No. 871.1. Society for Neuroscience, Washington, DC.
39. Sevak R. J., Koek W. and France C. P. (2005) Streptozotocin-induced diabetes differentially modifies haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy. Eur. J. Pharmacol. 517, 64-67.
40. Shuster L., Yu G. and Bates A. (1977) Sensitization to cocaine stimulation in mice. Psychopharmacology (Berl) 52, 185-190.
41. Stuber G. D., Evans S. B., Higgins M. S., Pu Y. and Figlewicz D. P. (2002) Food restriction modulates amphetamine-conditioned place preference and nucleus accumbens dopamine release in the rat. Synapse 46, 83-90.
42. Sumiyoshi T., Ichikawa J. and Meltzer H. Y. (1997) The effect of streptozotocin-induced diabetes on dopamine 2, serotonin 1A and serotonin 2A receptors in the brain. Neuropsychopharmacology 16, 183-190.
43. 3H]spiroperidol binding in streptozotocin- diabetic rats. J. Neurochem. 40, 1456-1459.
44. Van den Boss R., Cools A. R. and Ogren S. O. (1988) Differential effects of the selective D2-antagonist raclopride in the nucleus accumbens of the rat on spontaneous and d-amphetamine-induced activity. Psychopharmacology (Berl) 95, 447-451.
45. -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92, 21-55.
46. Zahniser N. R., Larson G. A. and Gerhardt G. A. (1999) In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors. J. Pharmacol. Exp. Ther. 289, 266-277.